According to Medicare Data Analyzed by SmartTRAK, Recent DOJ Prosecutions in the Cellular Tissue Product / Skin Substitute Market are the “Tip of the Iceberg”

Susan Paquette, the VP of the Wound division of SmartTRAK, recently posted an article on that company’s blog about the Cellular Tissue Product (CTP) / skin substitute industry. SmartTRAK provides market intelligence on industry trends and has been closely watching the...
What Claims Can Cellular Tissue Product / Skin Substitute Sales Reps Make About Wound Healing? A Closer Look at the Proposed List of 15 in the LCDs

What Claims Can Cellular Tissue Product / Skin Substitute Sales Reps Make About Wound Healing? A Closer Look at the Proposed List of 15 in the LCDs

A few weeks ago, I got a message from a Cellular Tissue Products / skin substitute sales rep telling me about the great results seen using his product in Wagner grade 3 DFUs, specifically over bone and tendon. I wondered how he could make those claims given that, as...
Two Nurse Practitioners Charged in Connection with APX Scheme with Fraudulent Application of Amniotic Products

Two Nurse Practitioners Charged in Connection with APX Scheme with Fraudulent Application of Amniotic Products

District of Arizona | Seven Charged in Arizona as Part of the Department of Justice’s 2024 National Health Care Fraud Enforcement Action | United States Department of Justice The fallout continues from the indictments of Alexandra Gehrke and Jeffrey King on charges of...
Is There a Justifiable Price Limit on Cellular Tissue Products (CTPs) / Skin Substitutes? Check Out the Article Now Available

Is There a Justifiable Price Limit on Cellular Tissue Products (CTPs) / Skin Substitutes? Check Out the Article Now Available

Dr. Marissa Carter and I have published, “Counting the Cost of Cellular and/or Tissue-Based Products in Diabetic Foot Ulcers: Is There a Justifiable Price Limit per Square Centimeter?” now available in Advances in Wound Care. Recently I asked readers to predict what...
2025 Medicare Physician Fee Schedule is Out (and CMS Did Not “Package Price” Cellular Tissue Products / Skin Substitutes in the Doctor’s Office)

2025 Medicare Physician Fee Schedule is Out (and CMS Did Not “Package Price” Cellular Tissue Products / Skin Substitutes in the Doctor’s Office)

The Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the 2025 Medicare physician fee schedule (PFS). The big question in our field was whether CMS would start “package pricing” CTPs/skin subs in the physician office. They didn’t –...